Skip to content

Development of an Artificial Intelligence Agent for Eye Disease

Development of an Artificial Intelligence Agent for Eye Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109824
Enrollment
Unknown
Registered
2025-09-25
Start date
2025-09-29
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular surface diseases (e.g. viral keratitis, bacterial keratitis, fungal keratitis, echinococcal amebic keratitis, pterygium, conical cornea, dry eye, other non-infectious keratitis), fundus disorders (e.g. age-related macular degeneration, diabetic macular edema, retinal vein occlusion macular edema, retinal detachment, other hereditary fundus disorders), orbital disorders (e.g. Graves' ophthal

Interventions

Observation Group:NA

Sponsors

Eye Hospital at Hangzhou of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosed with one of the following ophthalmic diseases: ocular surface diseases (e.g. viral keratitis, bacterial keratitis, fungal keratitis, echinococcal amebic keratitis, pterygium, conical cornea, dry eye, other non-infectious keratitis), fundus diseases (e.g. age-related macular degeneration, diabetic macular edema, retinal vein occlusion macular edema, retinal detachment, other hereditary fundus diseases), orbital diseases (e.g. Graves' eye disease, inflammatory pseudotumor, etc.), visual dysfunction (e.g. strabismus, amblyopia);and (e.g., Graves' ophthalmopathy, inflammatory pseudotumor, etc.), visual dysfunction (e.g., strabismus, amblyopia).

Exclusion criteria

Exclusion criteria: 1. Lack of imaging data; 2. Incomplete history; 3. Unknown diagnosis.

Design outcomes

Primary

MeasureTime frame
Perfusion/Vessel Density;Glandular defect rate and morphology;Macular central medulla thickness;Corneal nerve fiber density, corneal stroma inflammation;

Secondary

MeasureTime frame
Degree of exophthalmos, severity of strabismus;The extent of ocular lesions and the degree of inflammation.;

Countries

China

Contacts

Public ContactFenfen Li

Eye Hospital at Hangzhou of Wenzhou Medical University

lifenfen_wzmu@163.com+86 577 88193666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026